Haven't checked this ticker in a couple of years. Glad I made a pretty penny before it took a dump! I'm running out of toilet paper though - anyone want to donate me some shares so I use them to wipe my #$%$
was Savoy's stock tip for MNKD. I'm fully loaded and ready for this to rocket in the next couple of years. Thank you Savoy for aiding my early retirement. I hope everyone else loads up MNKD while it's cheap.
This is the reason I added more as well. I knew Afrezza was game-changing, but it seems even I underestimated just how revolutionary this truly is. Just imagine when all the happy patients turn into investors too.
If Mnkd receives cash they will not trade below cash value (cash received from afrezza sale) because they could simply buy back stock and reduce float. Shorts are screwed.
MNKD should release a PR about Afrezza reversing insulin resistance in some patients. Similar to how EYES PR's on single patient successes have caused multiple 30%+ rallies, we could see similar short squeezes here from a simple PR.
Shorts lack vision. There was a 30% short interest on TSLA when it was a 30$ stock, and they have been screaming all the way to $300 that TSLA was overvalued and only sells 25k cars a year. Guess what? MNKD is about to be "overvalued" with our revolutionary drug, as shorts touting overvalued from 5$ to 50$ complaining that we only have a few thousand scripts so far while missing the big picture.
The market is forward looking. Look at Tesla... they're worth half as much as ford which sells millions of cars, while Tesla only sells ~30,000 cars per year. We don't need millions of scripts for us to be valued as a blockbuster drug - the market simply needs to believe that our potential is millions of scripts, and if the positive experiences of afrezza users becomes viral this will happen much sooner than you expect.